Comments

Hikma Pharmaceuticals Stock Price, Quotes and Forecasts

HKMPFOTCPK
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers

Hikma Pharmaceuticals (HKMPF) Forecast

NewsEarningsHikma Pharmaceuticals (HKMPF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
Edge Rankings

Hikma Pharmaceuticals Stock Price, Quotes and Forecasts | OTC:HKMPF | Benzinga

Explore Hikma Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HKMPF.

Open-
Close-
Volume / Avg.0 / 1.86K
Day Range- - -
52 Wk Range22.56 - 28.92
Market Cap$6.15B
P/E Ratio17.22
Dividend Yield2.88%
ExchangeOTC
RSI
0
Short Interest-
Days to Cover999.99

Recent News

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.
Vandana Singh
Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and claim the company raised Xyrem's price by over 800%.
Vandana Singh
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March.  Methotrexate is an injected medication utilized to treat various cancers and autoimmune diseases like rheumatoid arthritis, as stated by the National Cancer Institute.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open-
Close-
Volume / Avg.0 / 1.86K
Day Range- - -
52 Wk Range22.56 - 28.92
Market Cap$6.15B
P/E Ratio17.22
Dividend Yield2.88%
ExchangeOTC
RSI
0
Short Interest-
Days to Cover999.99
About
Sector
Healthcare
Industry
N/A
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of ge...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HKMPF

FAQ

Q

How do I buy Hikma Pharmaceuticals (HKMPF) stock?

A

You can purchase shares of Hikma Pharmaceuticals (OTCPK:HKMPF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Hikma Pharmaceuticals (HKMPF) competitors?

A

There are no as such competitors for Hikma Pharmaceuticals.

Q

What is the forecast, or price target, for Hikma Pharmaceuticals (HKMPF) stock?

A

There is no analysis for Hikma Pharmaceuticals to provide a consensus price target.

Q

What is the current price for Hikma Pharmaceuticals (HKMPF)?

A

The stock price for Hikma Pharmaceuticals (OTCPK: HKMPF) is $27.7301 last updated May 20, 2025 at 2:52 PM EDT.

Q

Does Hikma Pharmaceuticals (HKMPF) pay a dividend?

A

There are no upcoming dividends for Hikma Pharmaceuticals.

Q

When is Hikma Pharmaceuticals (OTCPK:HKMPF) reporting earnings?

A

Hikma Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Hikma Pharmaceuticals (HKMPF) going to split?

A

There is no upcoming split for Hikma Pharmaceuticals.

Q

What sector and industry does Hikma Pharmaceuticals (HKMPF) operate in?

A

Hikma Pharmaceuticals is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved